| Correction of Nonsense BMPR2 and SMAD9 Mutations by Ataluren in Pulmonary Arterial Hypertension KM Drake, BJ Dunmore, LN McNelly, NW Morrell, MA Aldred American journal of respiratory cell and molecular biology 49 (3), 403-409, 2013 | 118 | 2013 |
| Increased mutagen sensitivity and DNA damage in pulmonary arterial hypertension C Federici, KM Drake, CM Rigelsky, LN McNelly, SL Meade, ... American journal of respiratory and critical care medicine 192 (2), 219-228, 2015 | 99 | 2015 |
| Levels of DNA damage are systemically elevated in patients with pulmonary arterial hypertension and can be suppressed with N-acetylcysteine MA Aldred, C Federici, L McNelly, SAA Comhair, SC Erzurum, KM Drake C53. CLINICAL EVALUATION AND BIOMARKERS OF PULMONARY HYPERTENSION II, A4769 …, 2014 | 1 | 2014 |
| Therapeutic Approaches To Correct Bmp Signaling In Heritable Pulmonary Arterial Hypertension KM Drake, BJ Dunmore, LN McNelly, NW Morrell, MA Aldred A17. NOVEL THERAPEUTIC TARGETS IN PULMONARY HYPERTENSION, A1026-A1026, 2013 | 1 | 2013 |
| Increased Susceptibility To DNA Damaging Agents In Pulmonary Arterial Hypertension Patients And Their Relatives MA Aldred, C Federici, L McNelly, KM Drake A54. GENETICS AND EPIGENETIC, A1991-A1991, 2015 | | 2015 |
